Fujifilm Wako Chemicals Europe Gmbh

What Fujifilm Wako Chemicals Europe Gmbh does

FUJIFILM Wako Chemicals Europe GmbH is a wholly-owned subsidiary of Japan's FUJIFILM Wako Pure Chemical Corporation, established in 1974 and headquartered in Neuss, Germany. The company manufactures and distributes in vitro diagnostic (IVD) reagents, specialty chemicals, and laboratory chemicals across the Europe, Middle East, and Africa (EMEA) region through a network of more than 25 distributors covering 27+ countries. Its primary end customers are clinical microbiology laboratories, hospitals and reference labs performing fungal-infection and hepatocellular carcinoma (HCC) diagnostics, pharmaceutical companies requiring endotoxin and pyrogen testing, and academic/biomedical research institutions.

The company's technology base centers on proprietary IVD platforms and reagent chemistries. Core instrumentation includes the LIMUSAVE MT-7500 kinetic-turbidimetric analyzer for beta-glucan detection (early invasive fungal infection screening) and the µTASWako i30 microfluidic immunoassay system, marketed as the only worldwide automated platform for HCC biomarkers AFP-L3 and DCP, delivering results in 9 minutes at 25 tests/hour throughput. Reagent chemistry assets include the L-Type lipid panel (HDL-C, LDL-C with within-run imprecision <1%), bilirubin assays, ketone body tests via cyclic enzymatic methods, the Autokit CH50 liposome immunoassay for complement activity, and the Hyaluronic Acid-LT assay for liver fibrosis staging. A patent-protected single B-cell cloning method (WO2024071374) supports a contract research service for rabbit monoclonal antibody discovery targeting TCR/CAR-T, ADC, and diagnostic applications. All IVD products are CE-certified under IVDR (EU) 2017/746, with quality systems certified to ISO 9001:2015 and EN ISO 13485:2016; a 2025 transition shifts legal manufacturer status to the Japan parent under IVDR.

Revenue is generated through three channels: one-time IVD reagent sales, hardware sales of proprietary diagnostic instruments and OEM test components, and professional services from the antibody discovery CRO. Pricing is not publicly disclosed; products are sold on an inquiry/quote basis either directly or through regional distributors. Go-to-market relies heavily on trade-show presence (MEDICA, CPHI, ECCMID, ISSCR, TIMM, DGHM-VAAM), sponsored webinars with key opinion leaders, and digital content via LinkedIn and newsletters. No revenue, headcount, or financial growth metrics are publicly disclosed, reflecting the entity's status as a privately held operating subsidiary consolidated within the FUJIFILM Group.

Name

Fujifilm Wako Chemicals Europe Gmbh

Legal name

FUJIFILM Wako Chemicals Europe GmbH

Website

https://wako-chemicals.de

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

11–50 employees

Short description

FUJIFILM Wako Chemicals Europe GmbH is a Neuss, Germany-based subsidiary of FUJIFILM Wako Pure Chemical Corporation (Japan) that manufactures and distributes CE-certified in vitro diagnostic reagents, proprietary diagnostic instruments (µTASWako i30, LIMUSAVE MT-7500), specialty chemicals, and laboratory chemicals to clinical labs, hospitals, pharmaceutical companies, and research institutions across the EMEA region.

Ownership category

akta.pro rank

Product category

Clinical Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• In vitro diagnostics
• Clinical chemistry reagents
• Diagnostic medical devices
• Specialty laboratory chemicals
• Microfluidic immunoassays

Headquarters

HQ city

Neuss

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagents and Tests: Sale of in vitro diagnostic (IVD) medical devices including reagent kits for clinical chemistry analyzers. Products include assays for beta-glucan, HCC biomarkers (AFP-L3, DCP), complement (CH50), lipids (HDL-C, LDL-C), bilirubin, hyaluronic acid, NEFA, ketone bodies. All products are CE-certified according to Regulation (EU) 2017/746 (IVDR).
2. Diagnostic Instruments and Equipment: Sale of proprietary diagnostic instruments including LIMUSAVE MT-7500 for beta-glucan testing and µTASWako i30 for HCC biomarker measurement. Extension modules, thermostations, and cooling stations also available. OEM test components offered for certain assays.
3. Specialty and Laboratory Chemicals: Supply of high purity chemicals and reagents from FUJIFILM Wako Pure Chemical Corporation. Products include endotoxin and pyrogen testing solutions (PYROSTAR ES-F, PYROSTAR Neo+, LumiMAT Pyrogen Detection Kit), CertiPro line for pharmaceutical raw materials, and general laboratory chemicals.
4. CRO Services - Rabbit Monoclonal Antibody Discovery: Contract research organization service for antibody production using DNA immunization and proprietary single B-cell cloning technique. Targets TCR/CAR-T therapies, ADCs, and diagnostic applications.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels6 records

Core offering

FUJIFILM Wako Chemicals Europe GmbH develops, manufactures, and distributes in vitro diagnostic (IVD) reagents, automated diagnostic instruments, and high-purity specialty and laboratory chemicals across the EMEA region. Its diagnostic portfolio focuses on clinical chemistry assays for lipid profiling (HDL-C, LDL-C), bilirubin, ketone bodies, complement activity (CH50), hyaluronic acid, non-esterified fatty acids, hepatocellular carcinoma biomarkers (AFP-L3, DCP), and (1→3)-β-D-glucan for invasive fungal infection detection. The company also provides Rabbit Monoclonal Antibody Discovery CRO services and supplies endotoxin/pyrogen testing solutions for pharmaceutical quality control.

Product overview

FUJIFILM Wako Chemicals Europe GmbH offers a comprehensive portfolio of in vitro diagnostic reagents and automated testing systems. The product portfolio centers on the µTASWako i30 Micro Total Analysis System, a proprietary automated platform that runs specific biomarker tests including AFP-L3 and DCP for hepatocellular carcinoma (HCC) risk assessment. Supporting this core system are standalone reagent assays including: L-Type lipid panel tests (HDL-C, LDL-C); bilirubin tests (Total and Direct); metabolic tests (Autokit 3-HB, Autokit Total Ketone Bodies, NEFA-HR(2)); complement assay (Autokit CH50); hyaluronic acid assay; and the Beta-Glucan Test for fungal infections run on the LIMUSAVE MT-7500 device. All diagnostic products are CE-certified under IVDR (EU) 2017/746. The company also offers laboratory chemicals and specialty chemicals through separate business units, with products distributed throughout the EMEA region via a network of regional distributors.

Differentiator

Problem solved

Functional benefit

Brands

• Wako: The Wako brand is used for chemicals and reagents products under FUJIFILM Wako Pure Chemical Corporation.

Products and services

• µTASWako i30 Micro Total Analysis System Automated diagnostic system that integrates immunoassay steps in disposable microfluidic microchips using Electrokinetic Analyte Transport Assay (EATA) with high-sensitivity fluorescence detection. Performs single tests in 9 minutes with throughput of 25 tests/hour and runs the AFP-L3 and DCP tests for hepatocellular carcinoma risk assessment. Intended for clinical laboratories performing HCC biomarker testing.
• µTASWako AFP-L3 Test In vitro diagnostic blood test measuring the ratio of AFP-L3 (lectin-reactive alpha-fetoprotein isoform) to total AFP as a percentage for early hepatocellular carcinoma (HCC) risk assessment. Run on the µTASWako i30 device. Intended for clinical laboratories and hospital diagnostic departments supporting HCC screening in high-risk patients.
• µTASWako DCP Test In vitro diagnostic test for des-gamma-carboxy prothrombin (DCP/PIVKA-II) measurement enabling early diagnosis of hepatocellular carcinoma. Run on the µTASWako i30 device. Intended for clinical laboratories performing HCC biomarker testing in high-risk patient populations.
• Beta-Glucan Test In vitro diagnostic test for quantitative determination of (1→3)-β-D-glucan in serum or plasma using LAL cascade reactions measured by the kinetic turbidimetric method. Used for early detection of invasive fungal infections. Intended for clinical microbiology laboratories, infectious disease specialists, and hospital epidemiologists. Maximum measurement time of 90 minutes per sample.
• LIMUSAVE MT-7500 Proprietary diagnostic device developed by FUJIFILM Corporation for quantitative measurement of (1→3)-β-D-glucan by kinetic turbidimetric assay. Features 10 measuring positions expandable to 30, touchscreen monitor, calibration via barcode, and LIMS compatibility. Used by clinical laboratories to run the Beta-Glucan Test for invasive fungal infection screening.
• L-Type HDL-C Assay In vitro diagnostic assay for quantitative determination of High Density Lipoprotein Cholesterol (HDL-C) in serum using immunoinhibition method with subsequent enzymatic reactions. Used in clinical laboratories for cardiovascular risk lipid profiling.
• L-Type LDL-C Assay In vitro diagnostic assay for quantitative determination of Low Density Lipoprotein Cholesterol (LDL-C) in serum and plasma using the Enzymatic Selective Protection Method. Demonstrates within-run imprecision below 1% and total precision below 1.5%. Used in clinical laboratories for cardiovascular risk lipid profiling.
• L-Type Total Bilirubin Assay Liquid stable reagent for quantitative determination of total bilirubin in serum using the vanadate oxidation method. Used in clinical laboratories for liver function assessment and pediatric jaundice evaluation.
• L-Type Direct Bilirubin Assay Liquid stable reagent for quantitative determination of direct bilirubin in serum and plasma using the vanadate oxidation method. Used in clinical laboratories for liver function assessment and differentiation of conjugated versus unconjugated hyperbilirubinemia.
• Autokit 3-HB Assay In vitro diagnostic assay for quantitative determination of 3-hydroxybutyrate (3-HB) in serum or plasma using cyclic enzymatic reactions. Used for metabolic syndrome diagnostics and diabetic ketoacidosis monitoring in clinical laboratories.
• Autokit Total Ketone Bodies Assay In vitro diagnostic assay for quantitative determination of total ketone bodies (acetoacetate plus 3-HB) in serum or plasma using cyclic enzymatic reactions, with calculation of acetoacetate concentration from 3-HB values. Used in clinical laboratories for diabetes diagnosis and liver transplant monitoring.
• Autokit CH50 Assay Automated liposome-based immunoassay (LIA) for quantitative determination of total complement activity (CH50) in human serum, using a homogeneous population of small-size liposomes (200 nm) with extended calibration stability and good correlation to Mayer's hemolytic method. Used by clinical laboratories for immune system abnormality diagnosis.
• Hyaluronic Acid-LT Assay In vitro diagnostic test for quantitative determination of hyaluronic acid in serum and plasma using latex agglutination turbidimetric method. Used as a key marker for liver fibrosis staging in clinical laboratories.
• NEFA-HR(2) Assay In vitro enzymatic colorimetric diagnostic test for quantitative determination of non-esterified fatty acids (NEFA) in serum. Used in clinical laboratories for metabolic syndrome diagnostics and lipid metabolism assessment.
• Rabbit Monoclonal Antibody Discovery CRO Service Contract research service for antibody production leveraging over 20 years of DNA immunization experience in rats and mice combined with the proprietary Single B-Cell Cloning Method (PAT: WO2024071374), yielding monoclonal antibodies with exceptional affinity and specificity. Targets TCR/CAR-T therapies, antibody-drug conjugates, and diagnostic applications for pharmaceutical and biotech clients.

Quantifiable outcome

• Beta-glucan test achieves results in 90 minutes maximum measurement time
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Fujifilm Healthcare Europe, FUJIFILM Middle East & Africa, FUJIFILM Healthcare Turkey, FUJIFILM PortugalcoreGTM or Marketing Partner · 11 November 2024Partnership and support from Fujifilm group companies including Fujifilm Healthcare Europe, FUJIFILM Middle East & Africa, FUJIFILM Healthcare Turkey, and FUJIFILM Portugal helped expand reach and strengthen global impact at MEDICA 2024 trade fair.
• Drug Discovery WorldcoreGTM or Marketing Partner · 9 September 2024Collaboration with Drug Discovery World for joint webinar on Rabbit Monoclonal Antibody Discovery. FUJIFILM showcased their DNA immunization and single B-cell cloning technology through this free webinar featuring expert presentations.
• Neuss City LibraryminorOthers · 29 May 2024FUJIFILM Wako donated 6000 euros to the Neuss City Library to support a series of STEM workshops focused on mathematics, engineering, science, and technology. The workshops use interactive techniques to explore robotics, chemistry, biology, programming, and AI. This commemorates the company's 50th anniversary.
• Biomedica Group (Multiple subsidiaries)coreChannel Partner/ Reseller/ DistributorBiomedica Group operates multiple subsidiaries across Central and Eastern Europe distributing FUJIFILM Wako diagnostic products, particularly the beta-glucan test. Subsidiaries include Biomedica Medizinprodukte (Austria), Biomedica d.o.o. (Bosnia), БиОМЕДИКА БЪЛГАРИЯ (Bulgaria), Biomedica dijagnostika (Croatia), Biomedica Hungària (Hungary), Biomedica Poland, Biomedica MP (Serbia), and Biomedica Slovakia.
• Sopachem NV/SAcoreChannel Partner/ Reseller/ DistributorDistributor for FUJIFILM Wako products in Belgium and Netherlands. Handles HCC-biomarker products and general diagnostic reagents in these markets.
• Assista Laborelectronics GmbHcoreChannel Partner/ Reseller/ DistributorAustrian distributor specializing in diagnostic reagents for FUJIFILM Wako products, located at Döblinger Hauptstraße 95, 1190 Wien.
• Alpha Laboratories Ltd.coreChannel Partner/ Reseller/ DistributorUK distributor for FUJIFILM Wako diagnostic products, located at 40 Parham Drive, Eastleigh SO50 4NU, Hampshire.
• Vircell Spain S.L.U.coreChannel Partner/ Reseller/ DistributorSpanish distributor specializing in beta-glucan test products, located at Plaza Domínguez Ortiz, 1, Polígono Industrial Dos de Octubre, 18320 Santa Fe, Granada.
• Nordic Biolabs ABcoreChannel Partner/ Reseller/ DistributorSwedish distributor for FUJIFILM Wako diagnostic products, located at P.O. Box 7293, 18714 Täby.
• Euromed Swiss AG and IGZ Instruments AGcoreChannel Partner/ Reseller/ DistributorSwiss distributors for FUJIFILM Wako products. Euromed Swiss AG at Langfeldstrasse 53A, 8500 Frauenfeld, and IGZ Instruments AG at Furtbachstrasse 17, CH-8107 Buchs ZH.
• E+S ChemieminorOthersPartner for STEM workshop series at Neuss City Library. Young chemists from E+S Chemie conducted interactive chemistry experiments and chemistry shows for the 'Night of the Libraries' event.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Siemens Healthineers: Major IVD incumbent whose Atellica and ADVIA Centaur systems run the same clinical chemistry and immunoassay menu (lipids, liver, complement) that Wako supplies reagents for. Comparable customers and application area, but operates at much larger scale and through direct sales.
• Roche Diagnostics: Global IVD market leader offering the full clinical chemistry, immunoassay and microbiology menu that overlaps with Wako's diagnostic reagent and instrument portfolio. Comparable on product category and end-customers (hospital labs, reference labs), but with vastly broader scale.
• Abbott Diagnostics: Operates ARCHITECT and Alinity ci-series analyzers covering clinical chemistry and immunoassays overlapping Wako's reagent menu. Comparable end-customer base (hospital and reference labs), but with a global direct-sales model that is broader than Wako's distributor-led EMEA footprint.

Direct peers

• Denka: Japanese chemical/IVD company with clinical chemistry and infectious disease diagnostics lines. Comparable as another Japan-headquartered specialty chemical + IVD firm with European distribution models similar to Wako's.
• DiaSorin: Italian specialty IVD company focused on immunoassay and molecular diagnostics for infectious disease and specialty markers. Comparable as a mid-size European-headquartered specialty IVD player with a similar niche/reagent-driven commercial profile.
• Eiken Chemical: Japanese IVD and clinical chemistry company selling LAL reagents, fecal immunochemical tests and molecular assays. Closest peer by origin (Japanese specialty chemical/IVD company), product mix (LAL/clinical chemistry) and EMEA distribution profile.
• bioMérieux: French IVD company specializing in microbiology diagnostics, including fungal infection detection (e.g., VITEK MS, BACT/ALERT blood culture). Directly comparable on the beta-glucan / invasive fungal infection diagnostics franchise and on EMEA regulatory positioning under IVDR.
• Sekisui Diagnostics: Specialty clinical chemistry and coagulation IVD company (Japan-rooted, global). Comparable on clinical chemistry reagent portfolio and on the Japanese-parent / global-distribution operating model that mirrors Wako's setup.
• Associates of Cape Cod / Charles River Endosafe: Direct competitor in LAL-based endotoxin and (1→3)-β-D-glucan testing, including kinetic turbidimetric assays on proprietary readers. Comparable product technology, regulatory positioning and end customers (pharma QC, hospital fungal diagnostics).

Emerging players

• The Binding Site (Thermo Fisher Scientific): Specialist in complement and immunoglobulin diagnostics (CH50-related assays, Freelite assays). Direct overlap with Wako's Autokit CH50 liposome immunoassay and with the autoimmune/immunology hospital lab customer segment.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fujifilm-wako-chemicals-europe

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fujifilm Wako Chemicals Europe Gmbh